D ifferent B cell lineages are mobilized in mice during T-dependent and T-independent immune responses. T-dependent responses against protein Ags drive recruitment of naive follicular B cells into germinal centers (GCs)
, where somatic hypermutation and isotype switching allow emergence of expanded IgG + and IgA + memory B cell clones with higher affinity for immunizing Ags. Recent evidence in mice demonstrates the existence of a mutated IgM memory compartment generated in parallel during the GC response (1, 2) , even though the precise conditions of its activation in subsequent Ag challenges are still a matter of debate. In contrast, mouse T-independent responses (e.g., those against polysaccharides from encapsulated bacteria) involve marginal zone (MZ) B cells, a distinct splenic subset with limited recirculation capacities that rapidly differentiate into effector plasma cells secreting IgM as well as IgG and IgA Abs after isotype switching (3) . The murine and human peripheral and splenic B cell compartments differ in many ways. In humans, subsets with mutated Ig genes are markedly expanded, accounting for ∼40% of B cells. Mutated B cells are identified by the CD27 marker, even though a small CD27 2 compartment that contains IgM + , IgG + , and IgA + has been identified in blood (4) (5) (6) . Switched CD27 + B cells are GC derived and are capable of accumulating a considerable number of mutations, while it was recently proposed that blood IgA + CD27
2 cells may have a T-independent origin, possibly originating in GALTs (7) . (8) . On the basis of the presence of such cells in CD40L-deficient patients (albeit in reduced numbers) that cannot initiate GC reactions, we proposed that MZ B cells prediversify their IgR outside immune responses (9) . This proposition was further supported by finding splenic MZ B cell Ig gene diversification in infants before the development of functional T-independent responses (10).
The presence of Ig V gene mutations in the IgM + IgD + CD27 + subset, however, is consistent with another interpretation (i.e., they represent IgM memory B cells that exited GCs prior to isotype switching) (11) . "IgM-only" CD27 + cells, a minor B cell subset with very low IgD expression, are similarly categorized (12) . The most striking evidence favoring the memory lineage argument is the observation of a large number of clonal relationships between blood IgG + CD27 + and IgM + IgD + CD27 + B cells through CDR3-specific PCR amplification (13) .
The relative relationship with other B cell subsets was investigated further by extensive phenotypic and molecular profiling and by high-throughput sequencing of Ig genes (7, 14) . In the latter study, clonal relationships were found between blood IgM + IgD + CD27 + and other IgM + B cell subsets (IgM-only and IgM + IgD 2 CD27
2 ) but not with switched CD27 + cells, although large-scale sequencing is less powerful than a CDR3-targeted PCR approach.
We addressed the origin of IgM memory subsets in humans using high-throughput sequencing of paired blood and spleen samples. For each subset, we identified a specific repertoire profile, based on V H gene mutation distribution, H-CDR3 size, and V H and J H usage. Surprisingly 
Materials and Methods

Samples
Paired blood and spleen samples were obtained from three organ donors (45-, 48-, and 54-y-old). All died of cerebral vascular accidents, and blood samples were taken before organ removal. The criteria for inclusion as organ donor include a noninfectious serology as well as normal blood parameters for standard metabolic markers and cell composition. These individuals can thus reasonably be considered as "healthy donors" at the time of their blood and spleen sampling. This study was authorized by the French Agence Nationale de la Biomédecine.
Cell sorting
PBMCs and splenocytes obtained by Ficoll-Hypaque density centrifugation were stained with the following anti-human Abs: V500 anti-CD19 (BD Biosciences), PerCPcy5.5 anti-CD38 (BioLegend), PE-cy7 anti-CD24 (BioLegend), FITC anti-IgD (Invitrogen), and allophycocyanin anti-CD27 (BD Biosciences). Dead cells were excluded by Sytox Blue staining (Invitrogen). B cells (1,000-20,000) were sorted using a FACSAria (BD Biosciences) and collected into 30 ml reverse transcription lysis buffer (14) .
V H gene amplification and sequencing
cDNA synthesis and isotype-specific seminested PCR amplification was performed as described previously (14) . Purified PCR products were used for high-throughput sequencing on Roche 434 Titanium platform (LGC Genomics). Sequences were processed as reported previously (14) .
Selection of unique sequences and H-CDR3 clustering
Identical sequences are predominantly generated by PCR amplification, and not through contribution of identical mRNA species because they present an inverse correlation with the initial cell input (data not shown). Only unique sequences were used for these analyses. Identical sequences were removed, including those differing only by insertions/deletions, which most probably were generated by the sequencing procedure, and by selecting the in-frame one. Among 152,981 sequences determined, 103,066 unique sequences were obtained.
Sequences from each donor were clustered based on CDR3 nucleotide sequences to identify clonally related sequences. CDR3 is defined as the nucleotide region comprised between the invariant Cys residue at the end of all V H genes and the invariant Trp from all J H segments. We empirically selected a 16.5% divergence cutoff for the CDR3 clustering algorithm (i.e., allowing for an 8-nt difference over an average CDR3 length of 16 aa). We arrived at this value by starting from a higher cutoff (20%), and performing a manual evaluation (described below) of a representative selection of the resulting clones. After subsequent clustering at lower cutoffs (0.5% interval), we selected the lower threshold that maintained the assessed clonal associations. It needs to be emphasized that the stringency of this cutoff depends upon the average mutation frequency of the subset analyzed, and accordingly, a higher stringency should be used for the analysis of naive B cells (not included in this study). All clusters with sequences belonging to two or more B cell subsets, isotypes, and/or tissues were manually aligned and, in the case of false positive associations, were assigned to a new cluster. The criteria used to evaluate the relevance of the clustering included the distribution of divergent positions along the CDR3 sequence (in the V, D, and J coding segments versus at the V-D and D-J junctions) as well as the number of shared mutations in the V gene sequence.
Estimate of clone size and B cell sampling
The size of a clone is the number of cells belonging to that clone, and this can be estimated from the number of sequences attributed to that clone in the sequence dataset, using Bayes' inversion rule. N represents the total number of cells under consideration (e.g., of a given cell type), and M the subset of these cells that belong to a given clone. Likewise, n represents the total number of sequences within that type, and m the subset of these that belong to the clone of interest. The naive estimate M = N 3 m/n could be quite inaccurate for very small clones (e.g., clones that have been seen once in the sequence dataset [m = 1]). Such clones could be of size of order ∼N/n, but they could also be much smaller. These, out of many similarly small clones, could randomly be assigned to the sequence dataset by chance. To better control what M could be based on our knowledge of m, we use Bayes' rule:
If we assume that the sequenced reads are a random subset of the cell receptors, P(m|M) is given by a Poisson distribution:
, in contrast, represents our prior information about the distribution of clone sizes. These distributions are typically observed to obey power laws, P(M) ∼ M 2n (in this paper we use nu = 1). The result of Bayes' procedure is a distribution over the possible values of M, P(M|m), rather than a single number. In the plots depicted in Supplemental Fig. 1B , we represent the median value of that distribution, with error bars showing 95% confidence intervals. The higher m is, the more reliable the estimate of M is, as evidenced by the shrinking error bars as m increases.
We used the lower estimate of the real size of each individual clone in the different subsets to estimate the minimal fraction of the total B cell subset that the sampled clones represent (described in Supplemental Fig. 1 and listed in Supplemental Table I ).
Statistics
For continuous variables, the unpaired t test was used and for proportions x 2 test was used; for both, Bonferroni corrections were included. Supplemental Table III lists the results of statistical tests performed for the repertoire analysis reported in Figs. 5 and 6. All repertoire characteristics include error bars representing the 95% confidence interval of the distribution.
Results
We used paired blood and spleen samples from three adult organ donors, who, to the best of our knowledge, did not present any overt pathology. We isolated three different CD19 + B cell populations according to surface CD27 and IgD expression: MZ (CD27 + IgD + ), classical memory (CD27 + IgD 2 ), and double-negative (DN; CD27 2 IgD 2 ) B cells. Surface expression of CD38 and CD24 was used to exclude transitional, GC, and plasma cells from the sorted populations (Fig. 1 ). Using isotype-specific H chain primers, IgM sequences were amplified from MZ B cells, whereas IgM, IgG, and IgA isotypes were amplified from both memory and DN cells (Mem_M, Mem_G, Mem_A, and DN_M, DN_G, and DN_A, respectively). After eliminating 49,975 duplicates, we obtained 91,294 unique IgH sequences from the three donors. These fell into 42,670 clonotypes after H-CDR3 clustering (Supplemental Table II ).
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We also isolated IgM sequences from naive B cells (N;  CD27 2 IgD + ) to estimate background mutations and for H-CDR3 length comparisons.
H-CDR3 clustering
The H-CDR3 clustering algorithm has to be sufficiently stringent to minimize the number of false clusters but flexible enough to not exclude sequences that differ because of somatic mutations or sequencing errors. Therefore, we empirically determined a threshold for inclusion of 16.5% sequence divergence and then systematically performed a manual screening of all clusters containing sequences from different populations, isotypes, and/or tissues (see Materials and Methods).
To estimate the errors (false clusters) generated by this algorithm, we ran the clustering algorithm on spleen sequences pooled from two different donors and performed a manual screening of the clusters containing sequences from both donors with the same selection criteria. False clustering can be influenced by the average mutation frequency and the number of sequences analyzed. The occurrence of false clusters varied for the different subsets, representing 2.4% for MZ and 0.1% for memory B cells; no shared clones were detected for DN B cells between donors. The fraction of clusters judged as real after manual screening among total clones was 0.6%, and this therefore represents the probability of having unrelated sequences clustering by chance (i.e., similar H chain rearrangements occurring in nonclonally related B cells).
Sampling and estimate of clone sizes and clonal diversity
The adult lymphoid compartment comprises ∼10 3 10 9 cells (5-25 3 10 9 ) in blood and 75 3 10 9 cells (70-80 3 10 9 ) in spleen (15) . Taking into account the B cell percentage observed in the lymphoid gate by flow cytometry, the B cell pool was estimated to 10, 23, and 24 3 10 8 B cells in blood and 25, 55, and 43 3 10 9 B cells in spleen for the three donors, respectively. We similarly estimated B cell numbers for each subset from flow cytometry data for each donor, which, in combination with the number of unique sequences obtained for each B cell population, allowed us to evaluate the extent of our sampling as a fraction of total B cells per subset (Supplemental Table I ). We collected roughly the same number of sequences for blood and spleen. Because blood is a 20-to 30-fold smaller reservoir for B cells, we achieved better sampling for the blood (10 24 -10
25
) than for the spleen (10
-10 26 ), even though these values are low in both cases (Supplemental Table I ).
Observing clonally related sequences clearly indicates the presence of expanded clones. Clones defined by only one sequence represented 56% on average of the clones of a given subset (with large variation; see Fig. 2 ) but, in terms of sequences, only 29% of the sequences of this subset. This proportion is further reduced if the total pool of sequences obtained for one individual is taken into account for defining clones with one sequence and represents then 47% of the clones and 24% of the sequences on average for each subset (Fig. 2) .
Using Bayes' rule and Poisson statistics, we extrapolated an estimated size of each sampled clone in each subset-tissue combination (see Materials and Methods), an extrapolation whose precision increases with the number of clonally related sequences. From this, we estimated the minimum fraction of the entire B cell subset that all sampled clones represent in vivo (Supplemental Table I and Supplemental Fig. 1 for the calculation procedure). Thus, despite small B cell sampling, sampled clones represent an average of at least 15% of the B cells in vivo in a given subset (Supplemental Table I ). For all subsets, B cell clones are larger in spleen compared with blood, consistent with the relative size of their B lymphocyte compartment (Supplemental Fig. 1 and data not shown).
Clonal relationships between subsets and tissues
Through H-CDR3 clustering, we found clones that were present in different B cell populations, isotypes, and tissues. Clustering of all sequences was first performed for each donor separately, and then clones falling within the same category (e.g., clones present in blood and spleen MZ subsets) were pooled for the three donors to obtain weighted averages in frequency estimates. The total numbers of shared clones is listed in Supplemental Table II , and the fraction they represent, related to the total number of clones in the subset/tissue, is depicted in Fig. 3 . The fraction of shared clones observed between two given subsets depends on the sampling size, the in vivo clone size distribution, and the total B cell numbers comprising each subset, making the observed fraction of shared clones not readily comparable. Nevertheless, this fraction represents a minimal estimate of the clonal relationships existing in vivo. A high frequency of clonally related sequences is observed between the Mem_A and the DN_A subset, and amounts to 9.5% of Mem_A and 12.5% of DN_A clones (Fig. 3A) . Clones shared with MZ B cells also represent a large part of the Mem_M and DN_M subsets. In contrast, even though MZ B cells represent the largest sequence set, they display the lowest frequency of clonal relationships with other subsets. All subsets studied presented clones shared between blood and spleen, the highest frequency being observed for MZ B cells (Fig. 3B) . The different B cell subsets can be characterized by mutation frequency and distribution, H-CDR3-length, and usage of V H family and J H genes. We found that blood subsets tended to carry more mutations than splenic ones (apart from DN_M; discussed below) and mutation frequencies varied based on individual subsets and isotypes (Fig. 4A ). With respect to V H gene family usage, the V H 1 family was rarely used by the various IgMpositive subsets, and the frequency of V H 4 family gene usage appeared to be the most consistent discriminating feature (Fig. 4B ). It should be noted that V H family distribution might be biased because of the amplification reaction (i.e., the frequency of V H 1 usage is less than in previous reports) (14) . Thus, we do not consider our result as an absolute estimate of the V H family repertoire, although it does serve as a valid tool to compare within B cell subsets as each was subjected to the same V H amplification protocol. For J H usage, J H 6( t h eJ H segment with the longest sequence contribution to H-CDR3) was the most variable (Fig. 4C) .
Of 42,670 clones, 1,629 clones contained sequences from blood and spleen for the same B cell subset and 1,681 contained sequences from different subsets, allowing us to trace their relationships. We therefore analyzed these different repertoire parameters in clones sharing sequences from different B cell populations, comparing their profiles with those of their subset of origin. For mutation frequency, the only parameter that can differ between sequences within a single clone, we analyzed sequences from each subset within a clone separately (see legend to Fig. 5 ). In Figs. 5 and 6, V gene mutations are represented both by mutation distribution (with six different 2% mutation intervals from 0-2% to .10%) and by the average mutation frequency. The statistical relevance of the comparisons depicted in these figures is listed in Supplemental Table III .
Clonal relationships between different B-cell subsets
IgM subsets: MZ, IgM-only (Mem_M), and DN (DN_M). The three IgM-positive subsets (Mem_M, MZ, and DN_M) differed from each other for all four parameters. Mutation frequency decreased from Mem_M to MZ and then to DN_M, a difference most noticeable in the mutation distribution plot by the marked different proportion of sequences in the 0-2% mutation range (Fig. 5A, first  row) . MZ and DN_M clones differed from Mem_M based on greater V H 4 and J H 6 usage (Fig. 5A, fourth and fifth rows) . DN_M differed from the other two due to its longer average H-CDR3 length (Fig. 5A, third row) .
Analyses of clonal relationships between IgM subsets showed that clones shared between each two-population combination (MZ/ Mem_M, MZ/DN_M, and Mem_M/DN_M) exhibited mutation distribution, V H and J H profiles similar to the Mem_M, even for MZ/DN_M where Mem_M was not part of the comparison (Fig. 5A) . Accordingly, clones shared between MZ and Mem_M diverged from the MZ subset with respect to these three parameters; shared Mem_M/DN_M clones differed from DN_M with respect to mutation frequency and J H usage; and shared MZ/ DN_M clones deviated from MZ and DN_M based on mutation frequency and J H usage.
A three-dimensional analysis of these different subsets based on mutation frequency and V H 4a n dJ H 6 usage is presented in Fig. 5D . This illustrates the closer proximity of all clones shared between two IgM-positive subsets with Mem_M B cells than with MZ or DN_M B cells. All IgM shared clones thus appeared to display a homogenous profile, similar to the Mem_M subset, regardless of the isolated B cell population from which these sequences originated. MZ/IgM-only and IgG/IgA memory subsets. Examination of clonal relationships between MZ and switched memory subsets (MZ/ Mem_G and MZ/Mem_A) indicated that shared clones displayed a Mem_M profile for V H and J H usage as well as for mutation (for the IgM sequences) (Fig. 5B) . Accordingly, shared clones diverged from MZ for mutations and V H repertoire. The switched sequences of the shared clones had a higher mutation frequency than the IgM ones, each matching the corresponding switched subset. Clonal relationships were analyzed for each donor separately, and the total number of clones belonging to the same category (e.g., clones shared between blood and spleen Mem_A subsets) was pooled from the three donors and reported to the total number of clones obtained in the corresponding subset for the three samples [e.g., total clones from blood Mem_A or spleen Mem_A subsets, first two columns (B)].
The clonal relationship between IgM and switched memory subsets was analyzed by combining IgG and IgA clones (38 clones in total). Shared clones (Mem_M/Mem_A-G) presented an IgMonly profile for V H and J H usage, with mutation frequency corresponding to the parent isotype-matching subset.
These data suggest that clones shared between the MZ and switched memory subsets present a repertoire profile similar to Mem_M/Mem_A-G shared clones and represent IgM-only B cells that underwent class switching with accumulation of additional mutations. Accordingly, these clones segregated close to the Mem_M subset in the three-dimensional plot (Fig. 5D ). MZ and DN_G/DN_A subsets. Finally, defining clonal relationships between MZ and switched DN subsets revealed that shared clones (MZ/DN_G and MZ/DN_A) exhibit a MZ profile for V H and J H usage and, for IgM sequences within these clones, for mutation frequency (Fig. 5C ), although the data are limited in amount (MZ/ DN_G: 16 clones, MZ/DN_A: 41 clones). Accordingly, both MZ/ DN_G and MZ/DN_A shared clones differed from Mem_M for mutation, and MZ/DN_A also differed from Mem_M for V H repertoire (other parameters were not statistically significant). Switched sequences within shared clones had a mutation frequency corresponding to the isotype-matching DN cells. MZ/ DN_G shared clones had H-CDR3 lengths similar to the DN parental subset, whereas differing from both MZ and Mem_M. MZ clones shared with DN_A and DN_G sequences were the only ones segregating close to the MZ subset in the three-dimensional plot (Fig. 5D) .
These data suggest that a small fraction of MZ B cells undergoes isotype switching and persists in the DN population. MZ B cell switching to IgG DN cells appears biased for clones bearing longer H-CDR3 than the bulk MZ B cell population.
Clonal relationships between blood and spleen subsets Memory B cells. Switched memory B cells differed between blood and spleen mainly by V H 4 usage, which was lower in spleen (Fig. 6A, fourth row) and, for Mem_A, for mutation frequency, which was higher in blood (Fig. 6A, first and second  rows) .
Clones shared between blood and spleen in the switched Mem IgG and IgA subpopulations displayed low V H 4u s a g ea n dm utation frequency for IgA, typical of the spleen (Fig. 6A, 6B) . Thus, it appeared that switched memory cells in the spleen recirculate in an unbiased manner, at least based on V H repertoire, whereas the blood counterparts comprise a mixture of splenic and other lymphoid tissue-derived memory B cells with different V H repertoires, contributing to its higher V H 4u s a g e . Moreover, for IgA but not for IgG, the total blood-contained clones had significantly more mutations than the ones shared with spleen, indicating that clones from other lymphoid tissues contributing to the blood repertoire carried Igs with higher mutation loads. The IgM-only memory subset displayed minor differences between tissues; thus analysis of the 43 shared clones was not informative (Fig. 6B) .
The closer proximity of clones shared between blood and spleen to the spleen compartment for switched memory B cells is illustrated on a two-dimensional plot of mutation frequency and V H 4 usage (Fig. 6C) . MZ B cells. MZ B cells in blood and spleen exhibited a V H profile opposite to that of the other subsets, with a lower V H 4 usage in the blood. MZ B cells clones shared between blood and spleen displayed a V H profile closer to the blood (low V H 4) and significantly different from spleen (Fig. 6B) , suggesting that splenic MZ B cells have a biased recirculation, consisting of those with alo werV H 4 representation. Accordingly, clones shared between blood and spleen segregated closer to the blood subset in the two-dimensional representation (Fig. 6C) . Thus, the blood MZ B cell population appears to be composed of a subset of splenic MZ B cells, suggesting that not all splenic MZ B cells recirculate equally. DN subsets. The switched DN subsets presented the same differences between blood and spleen as their CD27 + counterpart: higher V H 4 usage (and mutation frequency for DN_A) in blood. Similarly, shared clones for the DN IgG subset showed the same V H repertoire bias toward the splenic repertoire observed for memory IgG; the shared DN_A clones had in addition the same mutation bias observed for memory IgA, the only two parameters for which differences in the comparison with the two parent tissues reached statistical significance (data not shown). This suggests that switched cells show similar recirculation dynamics for both CD27 + and CD27 2 , with blood subsets containing both recirculating splenic cells and cells from other tissues.
DN IgM cells did not present a sufficient number of shared clones to perform such analysis. Nevertheless, blood and spleen subsets present consistent differences, notably in mutation distribution and H-CDR3 length (Fig. 7A) . In spleen, almost half of the clones displayed unmutated V H genes with H-CDR3s longer than naive B cells (18.6 versus 16.8 aa) (Fig. 7B) . In contrast, the mutated fraction carries H-CDR3s with a length comparable to the other mutated subsets. Segregation of these two parameters suggested that the DN_M subset included B cells having at least two different origins and that part of the mutated DN_M sequences corresponds to IgM-only B cells downmodulating surface CD27. The blood DN IgM subset was composed mainly of clones with low mutation (only twice the background of naive B cells) and long H-CDR3 (Figs. 4A, 5C ), suggesting a different recirculation of mutated and unmutated subsets or a downmodulation of the CD27 marker taking place upon splenic location or trafficking of IgM-only B cells.
A schematic representation of the main clonal relationships observed between subsets or tissues is provided in Fig. 8 .
Discussion
We performed high-throughput Ig V H DJ H sequencing of human B cell subsets from paired blood and spleen samples, to investigate clonal relationships between MZ B cells and other memory subsets as well as the recirculation dynamics of different B cell subsets between blood and spleen.
Sequences from seven different B-cell populations were collected from these two compartments based on cell sorting according to expression of surface IgD and CD27 (after excluding GCs or plasma cells) and on isotype-specific PCR amplification V H mutation frequency depicted as fraction of clones within six different 2% mutation intervals from 0-2% (left)t o .10% mutation frequency (far right); 2) average V H mutation frequency; 3) average H-CDR3 aa length; 4) V H family 1-6 usage v) J H 1-6 usage. The mutation data for shared clones (first and second row) is plotted separately for the sequences belonging to each of the two populations involved because, contrary to other parameters, V H mutations can vary between B cells belonging to the same clone. All analyses are based on clones, not sequences, and take into account, for mutation frequencies, the average mutation frequency of the clone. (D) Three-dimensional plot representation according to mutation frequency, V H 4 and J H 6 usage of clones shared between two IgM-positive subsets (filled blue dots) or between MZ or Mem_M and Mem_A/Mem-G or DN_A/DN_G (open blue dots). In the latter case, data concerning MZ clones shared with DN_A and DN_G subsets were pooled. Parental IgM subsets are represented by diamonds, red for MZ, green for DN_M, and black for Mem_M. Statistics are depicted in Supplemental Table III to facilitate reading, with the different pairwise comparisons indicated. Error bars represent the 95% interval of confidence of data distribution and therefore directly reflect the size of the sample analyzed.
Even though we collected and analyzed several thousand unique V H sequences, they still only represent a small sample of the total B cell pool, which is estimated to be ∼10
25 for blood B cell subsets and ∼10 26 for splenic ones. Surprisingly, despite this low sampling, a large number of nonidentical sequences were clonally related (91,294 sequences segregating into 42,670 clones). As mentioned in similar studies (6) , isolation of clonally related V H sequences indicates that B cell clones have undergone major clonal expansion, with estimated average clone sizes of
∼10
5 cells for blood and 10 6 for spleen. Clones having more than one sequence within a subset represented 40-50% of the total number of clones obtained (i.e., ∼70% of the total sequences). Moreover, an average of 16% of clones composed by a single sequence within a subset appeared to have a clonal relative in another subset or tissue of the same individual, suggesting that expanded clones represent a major fraction of each B cell subset and not a minor one.
Interestingly, after extrapolating to the in vivo size of the B cell clones, we calculated that the sampled clones represented at least 15% of the total B cells in the compartment, in striking contrast with the 10 25 -10 26 sampling performed. Estimating the global repertoire diversity of these different subsets was not within the scope of this study because it would require sequencing of multiple samples of the same B cell population to estimate whether expanded clones are distributed along a normal distribution of sizes, a likely possibility for classical memory subsets, or distributed bi-or multimodally, thus corresponding to a much larger repertoire diversity. The focus of this study was the investigation of clonal relationships between subsets and tissues. We used an "intermediate" high-throughput approach that generated tens of thousands but not hundreds of thousands of sequences, allowing a relatively easy manual assessment of clones obtained through the clustering program, a critical point for their validity and for the relevance of the conclusions obtained. The number of sequences collected was nevertheless sufficiently large to define a robust repertoire signature for each individual subset and for most combinations of shared clones between two given populations. This subset-specific signature was based on mutation frequency and distribution, V H repertoire (V H 4 gene family usage that appears to be the most discriminating parameter), J H repertoire (notably J H 6 usage), and H-CDR3 length.
One Fig. 8B ).
Clonal relationships between tissues further distinguished MZ from switched B cells. In effect, switched memory B cell clones shared between blood and spleen had the spleen repertoire profile of the corresponding memory subset, suggesting, possibly not unexpectedly, that B cells from multiple lymphoid compartments and harboring a different repertoire profile contribute to the memory recirculating pool. For IgA memory B cells, clones contributed by other lymphoid tissues carry Ig with a higher mutation load, which would be consistent with a possible mucosal origin, a tissue in which IgA + B cells display the highest mutation frequency (16). Recirculating MZ clones had a signature significantly closer to the blood subset, suggesting, in contrast, that recirculation concerns a subset of splenic MZ B cells with a distinct repertoire (Fig. 8A) hallmark of autoreactive Igs (20) and broadly neutralizing anti-HIV Abs (21) .
Post-GC IgM memory B cells have been documented in mouse and appear to represent a population numerically equivalent to switched ones (1, 22) . The issue of their existence, number, and function in humans is, however, more confused. Several reports documented the presence of IgM memory B cells in specific responses, notably in alloimmunized individuals following blood transfusions, but their surface phenotype, IgD + or not, has not been addressed (23) . IgM-only B cells are found in AID-deficient patients, who lack switched B cells but have active GC reactions (8, 24) . This observation suggested that IgD downmodulation taking place during the GC reaction might be conserved in GCderived cells that did not isotype switch. However, this observation did not preclude a heterogeneous IgD expression profile. IgM memory B cells, assessed as IgM-only cells, appear in most cases as a minor subset in humans (2-3%), whereas switched memory averages 20% (8) . We estimated, based on their distinct mutation profiles, that they may represent up to 15% of MZ clones: these figures would indicate that IgM memory B cells may in fact be broadly distributed over the IgD + and IgD 2 CD27 + B cell gates. In conclusion, the "IgM-only" subset (including cells with its repertoire signature but higher IgD or lower CD27 expression levels) appears as the only subset showing precursor-product relationships with CD27 + switched memory B cells, indicating that they represent GC-derived IgM memory B cells. MZ B cells, in contrast, only present a few clones in common with CD27
2 IgG and IgA cells, involving, in the former case, MZ B cells with a distinct repertoire. Uncovering new surface markers that may allow the unambiguous identification of the MZ and IgM memory compartments will be key toward studying the conditions of their mobilization and better delineating their respective contributions to T-dependent and T-independent immune responses.
